与美联储“划界限”?ECB管委:太晚降息有风险,首降应在4或6月!
- 0001年1月1日
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Evaxion Biotech A/S是一家丹麦的临床阶段生物技术公司,专门从事AI驱动的免疫疗法的开发业务,以改善癌症患者和传染病患者的生活。该公司对人类免疫系统进行解码,以发现和开发用于治疗癌症和传染病的免疫疗法。基于AI免疫核心技术,Evaxion正在开发一系列候选产品。此外,该公司还开发了一系列疫苗来预防细菌和病毒感染。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Soren Brunak | - | - | Member of Advisory Board |
Robert J. Palay | 67 | - | Member of Advisory Board |
Jeffrey S. Weber | - | - | Member of Advisory Board |
Thomas Wylonis | - | - | Member of Advisory Board |
Roberto Prego Pineda | 53 | 2018 | Independent Director |
Michael W. Washabaugh | - | - | Member of Advisory Board |
Lars Holtug | 65 | 2021 | Independent Director |
Anthony Purcell | - | - | Member of Advisory Board |
Andrew C. Webber | - | - | Member of Advisory Board |
Rajeev Surati | - | - | Member of Advisory Board |
Jürgen Langhärig | - | 2019 | Head of Business Development & Member of Advisory Board |
Niels Iversen Moller | 45 | 2008 | Co-Founder, VP of Business & Director |
Marianne Sogaard | 56 | 2020 | Independent Chairwoman of the Board |
Steven J. Projan | 72 | - | Director |
Georgina Long | - | - | Member of Advisory Board |
Kirsten Aarup Drejer | 68 | 2021 | Member of Advisory Board |
Patrick Ott | - | - | Member of Advisory Board |
Christian Schilling | - | - | Member of Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核